Amgen 2009 Annual Report Download - page 179

Download and view the complete annual report

Please find page 179 of the 2009 Amgen annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 180

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109
  • 110
  • 111
  • 112
  • 113
  • 114
  • 115
  • 116
  • 117
  • 118
  • 119
  • 120
  • 121
  • 122
  • 123
  • 124
  • 125
  • 126
  • 127
  • 128
  • 129
  • 130
  • 131
  • 132
  • 133
  • 134
  • 135
  • 136
  • 137
  • 138
  • 139
  • 140
  • 141
  • 142
  • 143
  • 144
  • 145
  • 146
  • 147
  • 148
  • 149
  • 150
  • 151
  • 152
  • 153
  • 154
  • 155
  • 156
  • 157
  • 158
  • 159
  • 160
  • 161
  • 162
  • 163
  • 164
  • 165
  • 166
  • 167
  • 168
  • 169
  • 170
  • 171
  • 172
  • 173
  • 174
  • 175
  • 176
  • 177
  • 178
  • 179
  • 180

Amgen Inc. Corporate Offi ce
One Amgen Center Drive
Thousand Oaks, California 91320-1799
(805) 447-1000
Amgen 2009 Annual Report Summary and SEC Form 10-K
Additional copies of the Company’s Form 10-K for the year ended December 31,
2009, fi led with the Securities and Exchange Commission, are available without
charge, upon written request to Investor Relations, Amgen Inc., One Amgen Center
Drive, Thousand Oaks, California 91320-1799, or by calling (800) 84-AMGEN,
or by accessing the Company’s website at www.amgen.com.
Transfer Agent and Registrar
American Stock Transfer & Trust Company
59 Maiden Lane
New York, New York 10038
Stockholder Inquiries
Inquiries related to stock transfers or lost certifi cates should be directed to
American Stock Transfer & Trust Company, (800) 937-5449 or (212) 936-5100
(www.amstock.com). General information regarding the Company and recent
news releases can be obtained by calling Amgen’s automated stockholder
information line at (800) 84-AMGEN, or by accessing the Company’s website
at www.amgen.com.
Independent Registered Public Accounting Firm
Ernst & Young LLP
Los Angeles, California
Annual Meeting
The Annual Meeting will be held on Wednesday, May 12, 2010, at 11 a.m. at
the Four Seasons Hotel Westlake Village, Two Dole Drive, Westlake Village,
California 91362.
Price Range of Common Stock
The Company’s common stock trades on the NASDAQ Stock Market under the
symbol AMGN. No cash dividends have been paid on the common stock to date,
and we currently do not intend to pay any dividends.
The following table sets forth, for the fi scal periods indicated, the range of high
and low closing sales prices of the common stock as quoted on the NASDAQ
Stock Market for the years 2009 and 2008.
Stockholder Information
Hotlines
Customer Service (800) 28-AMGEN | Investor Materials (800) 84-AMGEN
Medical Information (800) 77-AMGEN | Amgen Assist™ (800) 272-9376
Amgen, Amgen Assist™, Aranesp®
, Breakaway from Cancer ®
, Enbrel®
, EPOGEN®
,
Mimpara®
, Neulasta®
, NEUPOGEN®
, Nplate®
, Prolia™, Sensipar®
, and Vectibix®
are trademarks of Amgen Inc. or its wholly owned subsidiaries.
Design by Saputo Design, Inc.
Page 6 photographs by Yesikka Vivancos (top) and Andrew J. Tao (center)
2009 2008
High Low High Low
4th Quarter $ 61.83 $ 52.12 $ 61.55 $ 47.76
3rd Quarter 64.41 51.47 65.89 48.64
2nd Quarter 53.11 45.11 47.16 41.49
1st Quarter 59.65 46.27 48.14 39.97
Board of Directors
Leadership
David Baltimore
President Emeritus and Robert
Andrews Millikan Professor of Biology,
California Institute of Technology
Frank J. Biondi, Jr.
Senior Managing Director,
WaterView Advisors LLC
François de Carbonnel
Former Chairman of the Board
and Director, Thomson S.A. and
Director of Corporations
Jerry D. Choate
Retired Chairman and CEO,
The Allstate Corporation
Vance D. Coffman
Retired Chairman
of the Board and CEO,
Lockheed Martin Corporation
Frederick W. Gluck
Former Managing Director,
McKinsey & Company, Inc.
Rebecca M. Henderson
Faculty, Harvard Business School
Frank C. Herringer
Chairman and Retired CEO,
Transamerica Corporation
Gilbert S. Omenn
Professor of Internal Medicine,
Human Genetics & Public Health
and Director of the Center for
Computational Medicine and
Bioinformatics, University of Michigan;
Former CEO, University of Michigan
Health System
Judith C. Pelham
President Emeritus,
Trinit y Health
Adm. J. Paul Reason,
USN (Retired)
Former Vice Chairman and President,
Metro Machine Corporation
Leonard D. Schaeffer
Chairman,
Surgical Care Affi liates
Kevin W. Sharer
Chairman of the Board,
CEO and President, Amgen Inc.
Madhavan Balachandran
Senior Vice President,
Manufacturing
David W. Beier
Senior Vice President,
Global Government and
Corporate Affairs
Fabrizio Bonanni
Executive Vice President,
Operations
Robert A. Bradway
Executive Vice President
and Chief Financial Offi cer
James M. Daly
Senior Vice President,
North America Commercial
Operations
Willard H. Dere
Senior Vice President
and International Chief
Medical Offi cer
Paul R. Eisenberg
Senior Vice President,
Global Regulatory Affairs
and Safety
Thomas J. Flanagan
Senior Vice President and
Chief Information Offi cer
Sean E. Harper
Senior Vice President,
Global Development, and
Corporate Chief Medical Offi cer
Rolf K. Hoffmann
Senior Vice President,
International Commercial
Operations
David L. Lacey
Senior Vice President,
Research
Brian M. McNamee
Senior Vice President,
Human Resources
Joseph P. Miletich
Senior Vice President,
Research and Development
George J. Morrow
Executive Vice President,
Global Commercial Operations
Roger M. Perlmutter
Executive Vice President,
Research and Development
Anna S. Richo
Senior Vice President and
Chief Compliance Offi cer
David J. Scott
Senior Vice President,
General Counsel and Secretary
Kevin W. Sharer
Chairman of the Board,
CEO and President
Geoffrey F. Slaff
Senior Vice President,
Process and Product Engineering
Martin VanTrieste
Senior Vice President,
Quality